Samsung Biologics plans to allocate KRW2.71T for PolyPeptide acquisition
Plans to allocate about KRW2.71T of offering proceeds to buy PolyPeptide Group and KRW290B for expansion of Bio Campus II.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.